Outcomes of artificial urinary sphincter implantation in patients with diabetes mellitus: A subgroup analysis.


Journal

International journal of urology : official journal of the Japanese Urological Association
ISSN: 1442-2042
Titre abrégé: Int J Urol
Pays: Australia
ID NLM: 9440237

Informations de publication

Date de publication:
12 2022
Historique:
received: 22 03 2022
accepted: 03 08 2022
pubmed: 15 9 2022
medline: 20 12 2022
entrez: 14 9 2022
Statut: ppublish

Résumé

To estimate the surgical and quality-of-life outcomes of artificial urinary sphincter implantation in patients with diabetes mellitus (DM). Subanalyses were performed using the same population as that in our previous multicenter, prospective, observational study. A total of 135 male patients who underwent primary artificial urinary sphincter implantation were divided into two groups: those with and without DM. The revision-free rates, that is, the percentage of patients who did not require revision surgery, were compared between patients with and without DM. The number of urinary pads required per day, International Consultation on Incontinence Questionnaire-Short Form, and King's Health Questionnaire were used to compare the continence status and quality of life (QOL) between the two groups preoperatively and at 1, 3, and 12 months after surgery. Revision-free rates were significantly lower in the DM group (83.9%, 77.4%, and 67.8% at 1, 2, and 3 years after implantation, respectively) than in the non-DM group (95.5%, 92.5%, and 85.5% at 1, 2, and 3 years after implantation, respectively). Both continence status and QOL, assessed by questionnaires, markedly improved after surgery in patients with and without DM. Despite differences in the durability of the artificial urinary sphincters, patients with DM can obtain as much benefit from artificial urinary sphincter implantation regarding continence and quality-of-life improvement as patients without DM. Therefore, DM was not considered a comorbidity that contraindicated artificial urinary sphincter implantation. Additional large-scale studies are required to verify our findings.

Identifiants

pubmed: 36102589
doi: 10.1111/iju.15025
doi:

Types de publication

Observational Study Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1498-1504

Informations de copyright

© 2022 The Japanese Urological Association.

Références

Walsh IK, Williams SG, Mahendra V, Nambirajan T, Stone AR. Artificial urinary sphincter implantation in the irradiated patient: safety, efficacy and satisfaction. BJU Int. 2002;89:364-8.
Deruyver Y, Schillebeeckx C, Beels E, De Ridder D, Van der Aa F. Long-term outcomes and patient satisfaction after artificial urinary sphincter implantation. World J Urol. 2021;40:497-503.
Van der Aa F, Drake MJ, Kasyan GR, Petrolekas A, Cornu JN. The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence. Eur Urol. 2013;63:681-9.
Bentellis I, el-Akri M, Cornu JN, Brierre T, Cousin T, Gaillard V, et al. Prevalence and risk factors of artificial urinary sphincter revision in nonneurological male patients. J Urol. 2021;206:1248-57.
Arai Y, Takei M, Nonomura K, Baba S, Habuchi T, Matsuda T, et al. Current use of the artificial urinary sphincter and its long-term durability: a nationwide survey in Japan. Int J Urol. 2009;16:101-4.
Viers BR, Linder BJ, Rivera ME, Andrews JR, Rangel LJ, Ziegelmann MJ, et al. The impact of diabetes mellitus and obesity on artificial urinary sphincter outcomes in men. Urology. 2016;98:176-82.
Khouri RK Jr, Ortiz NM, Dropkin BM, Joice GA, Baumgarten AS, Morey AF, et al. Artificial urinary sphincter complications: risk factors, workup, and clinical approach. Curr Urol Rep. 2021;22:30.
Godwin CA, Linder BJ, Rivera ME, Ziegelmann MJ, Elliott DS. Effects of smoking status on device survival among individuals undergoing artificial urinary sphincter placement. Am J Mens Health. 2018;12:1398-402.
Kaiho Y, Masuda H, Takei M, Hirayama T, Mitsui T, Yokoyama M, et al. Surgical and patient reported outcomes of artificial urinary sphincter implantation: a multicenter, prospective, observational study. J Urol. 2018;199:245-50.
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-55.
Owens WD, Felts JA, Spitznagel EL Jr. ASA physical status classifications: a study of consistency of ratings. Anesthesiology. 1978;49:239-43.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-13.
Donovan J, Badia X, Corcos J, et al. Symptom and quality of life assessment. In: INCONTINENCE. 2nd International Consultation on Incontinence. Plymouth, UK: Plymbridge Distributiors Ltd; 2001. p. 267-316.
Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol. 1997;104:1374-9.
Gotoh M, Homma Y, Funahashi Y, Matsukawa Y, Kato M. Psychometric validation of the Japanese version of the international consultation on incontinence questionnaire-short form. Int J Urol. 2009;16:303-6.
Homma Y, Ando T, Yoshida M, et al. Validation of the Japanese version of QOL questionnaires for urinary incontinence. NBS. 2002;13:247-57.
McMaster Arthroplasty Collaborative. Incidence and predictors of prosthetic joint infection following primary Total knee arthroplasty: a 15-year population-based cohort study. J Arthroplast. 2022;37:367-72.
Gon LM, de Campos CCC, Voris BRI, Passeri LA, Fregonesi A, Riccetto CLZ. A systematic review of penile prosthesis infection and meta-analysis of diabetes mellitus role. BMC Urol. 2021;21:35.
Husch T, Kretschmer A, Thomsen F, et al. Risk factors for failure of male slings and artificial urinary sphincters: results from a large middle European cohort study. Urol Int. 2016;99:14-21.
Japan Diabetes Society. Treatment guide for diabetes 2010. Tokyo: Bunkodo; 2010.
Japan Diabetes Society. Evidence-based practice guideline for the treatment for diabetes in Japan 2010. Tokyo: Nankodo; 2010.
Viers BR, Linder BJ, Rivera ME, Rangel LJ, Ziegelmann MJ, Elliott DS. Long-term quality of life and functional outcomes among primary and secondary artificial urinary sphincter implantations in men with stress urinary incontinence. J Urol. 2016;196:838-43.

Auteurs

Yasuhiro Kaiho (Y)

Department of Urology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Urology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Hitoshi Masuda (H)

Department of Urology, Tokyo Medical and Dental University, Bunkyo-ku, Japan.
Department of Urology, National Cancer Center Hospital East, Kashiwa, Japan.

Mineo Takei (M)

Department of Urology, Harasanshin Hospital, Fukuoka, Japan.

Takahiro Hirayama (T)

Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.

Takeya Kitta (T)

Department of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Japan.

Minato Yokoyama (M)

Department of Urology, Tokyo Medical and Dental University, Bunkyo-ku, Japan.

Naoki Kawamorita (N)

Department of Urology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Takahiko Mitsui (T)

Department of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Department of Urology, University of Yamanashi Graduate School of Medical Sciences, Chuo, Japan.

Haruo Nakagawa (H)

Department of Urology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Izumi Chuo Hospital, Sendai, Japan.

Masatsugu Iwamura (M)

Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.

Yoichi Arai (Y)

Department of Urology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Urology, Miyagi Cancer Center, Natori, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH